Healthcare Outcomes Performance Company acquired Caro Health, an artificial intelligence-driven company, according to an Aug. 7 news release.
Caro Health is based in the Netherlands and was founded in 2019. Its proprietary AI platform is designed for personalized communications with patients and providers.
As part of the acquisition, Caro Health’s platform and team will be fully integrated into HOPCo’s Digital Health division. Caro Health will help with AI augmentation for products including HOPCo Vitals and myrecovery by HOPCo.
Thomas Goijarts, founder and CEO of Caro Health will serve as head of products for HOPCo and will support customer service and delivery for HOPCO’s footprint in Europe.
“We have been hugely impressed with Caro’s thoughtful approach to integrating Conversational AI into complex clinical workflows,” Dr. Tom Harte, president of HOPCo Digital, said in the release. “he Caro team has clearly demonstrated that, when partnering with physicians to combine best-in-class technology with deep clinical expertise, Conversational and Generative AI can enhance both patient experience and operational workflow. This enables both physicians and administrators to focus on delivering patient care.”
